SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
风风
Lv3
360 积分
2023-06-06 加入
最近求助
最近应助
互助留言
Immune Checkpoint Inhibitors Therapy as the Game-Changing Approach for Pediatric Lymphoma: A Brief Landscape
1个月前
已完结
MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer
1个月前
已完结
Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidence
1个月前
已完结
Therapeutic adherence in patients treated with PCSK9i: focus on skin side effects
1个月前
已完结
Tildrakizumab for Moderate-to-Severe Plaque Psoriasis
1个月前
已关闭
Dupilumab to treat drug reaction with eosinophilia and systemic symptoms: A case series
1个月前
已完结
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab‐induced psoriasis
1个月前
已完结
Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects
1个月前
已完结
JAAD Game Changer: “Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort”
1个月前
已完结
Omalizumab-induced paradoxical urticaria responsive to dupilumab
1个月前
已完结
没有进行任何应助
感谢,帮大忙了
1个月前
感谢,速度真快
1个月前
感谢,帮大忙了
1个月前
感谢,速度真快,帮大忙了
1个月前
已找到原文【积分已退回】
1个月前
速度真快,点赞
1个月前
速度真快,帮大忙了,么么哒
1个月前
点赞,速度真快,帮大忙了
1个月前
点赞,速度真快,帮大忙了
2个月前
点赞,帮大忙了
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论